Literature DB >> 21196273

RhoA can lead the way in tumor cell invasion and metastasis.

Amanda P Struckhoff1, Manish K Rana, Rebecca A Worthylake.   

Abstract

The Rho family of GTPases is well-established regulators of cell migration, and has been implicated in the process of tumor cell invasion and metastasis. The RhoA signaling pathway is strongly correlated with the ability of tumor cells to invade and successfully establish metastases. In this review, we begin by discussing the gene expression data correlating Rho expression with metastasis, and then discuss two emerging concepts that help explain the underlying mechanisms by which RhoA may promote tumor metastasis. First, the use of sophisticated biosensor probes has revealed that RhoA is active in membrane protrusions. Second, the RhoA pathway affects the invasive behavior of tumor cells by promoting invadopodia, amoeboid migration, and the plasticity of tumor cells to modulate their migratory properties. Thus, our view of the role of the RhoA pathway in metastasis is evolving to include a previously unappreciated function at the leading edge.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196273     DOI: 10.2741/3830

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  32 in total

1.  Regulation of ROCKII membrane localization through its C-terminus.

Authors:  Swapnil S Kher; Rebecca A Worthylake
Journal:  Exp Cell Res       Date:  2011-10-01       Impact factor: 3.905

2.  The role of RhoA in vulvar squamous cell carcinoma: a carcinogenesis, progression, and target therapy marker.

Authors:  Jing Wang; Qiong Wu; Li-Hua Zhang; Yun-Xia Zhao; Xin Wu
Journal:  Tumour Biol       Date:  2015-09-26

3.  C-terminal di-arginine motif of Cdc42 protein is essential for binding to phosphatidylinositol 4,5-bisphosphate-containing membranes and inducing cellular transformation.

Authors:  Jared L Johnson; Jon W Erickson; Richard A Cerione
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

4.  Differential proteomic analysis of pathway biomarkers in human breast cancer by integrated bioinformatics.

Authors:  Liu Fu-Jun; Jin Shao-Hua; Shen Xiao-Fang
Journal:  Oncol Lett       Date:  2012-08-24       Impact factor: 2.967

5.  miR-126: A novel regulator in colon cancer.

Authors:  Weina Huang; Jie Lin; Hongxuan Zhang
Journal:  Biomed Rep       Date:  2015-12-02

6.  RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).

Authors:  Emilie Malissein; Elise Meunier; Isabelle Lajoie-Mazenc; Claire Médale-Giamarchi; Florence Dalenc; Sophie F Doisneau-Sixou
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-06       Impact factor: 4.553

7.  MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway.

Authors:  Nan Li; Anliu Tang; Shuo Huang; Zeng Li; Xiayu Li; Shourong Shen; Jian Ma; Xiaoyan Wang
Journal:  Mol Cell Biochem       Date:  2013-04-25       Impact factor: 3.396

8.  Role of km23-1 in RhoA/actin-based cell migration.

Authors:  Qunyan Jin; Nageswara R Pulipati; Weidong Zhou; Cory M Staub; Lance A Liotta; Kathleen M Mulder
Journal:  Biochem Biophys Res Commun       Date:  2012-10-15       Impact factor: 3.575

9.  Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion.

Authors:  Xiuping Zhou; Zhi Liu; Qiong Shi; Jiantong Jiao; Wenbin Bian; Xu Song; Jianbing Mo; Ben Sang; Yinfu Xu; Jinming Qian; Yuewen Chao; Rutong Yu
Journal:  J Neurooncol       Date:  2013-03-09       Impact factor: 4.130

10.  PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.

Authors:  Amanda P Struckhoff; Manish K Rana; Swapnil S Kher; Matt E Burow; Joseph L Hagan; Luis Del Valle; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2013-07-18       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.